DUBLIN, Nov. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ct7g76/chinese_market) has announced the addition of the "Chinese Market for Orthopedic Large Joint Replacement Devices - 2016 (Forecasted to 2022)" report to their offering.
The Chinese orthopedic large joint device market includes the hip replacement device and knee replacement device markets as well as the auxiliary bone cement market. The Chinese large joint market will reach over $1.3 billion by 2020. The large joint arthroplasty market is growing in each segment as demand rises from an aging population and a higher average income allowing patients to opt for more elective surgeries. Cemented knee replacement devices are commonly used in China, which results in a fairly large bone cement market given the fairly low average selling prices of this market.
The market has growing unit sales within all three of its segments: hip devices, knee devices and bone cement. Growth is driven primarily from the burgeoning elderly demographic, which is most at risk of osteoarthritis. Moreover, as average income levels rise, patients will choose not to postpone elective surgeries, which will raise procedure numbers and in turn propel the revision device markets.
The largest competitor in the Chinese large joint replacement device market was Zimmer Biomet. The merging of Zimmer and Biomet in June 2015 resulted in a clear market leader. Mergers such as these remain the most significant manner in which market shares change drastically.
Other competitors included in the study are Zimmer Biomet, Smith & Nephew, DePuy Synthes, Stryker, Aikang Yicheng, Baimtec Jinghang, Teijin Nakashima Medical and Tianjin Walkman.
This 166 Page Report Includes:
Key Topics Covered:
Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/ct7g76/chinese_market
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article